Medidata Solutions (MDSO) Tops Q4 EPS by 7c, Offers FY17 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Nasdaq ends higher as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
- AMD gets bullish pre-earnings call from Lynx as server CPU demand accelerates
- Marathon Petroleum to sell two refineries to CVR Energy for $4.2B
- Moderna shares rise ahead of Thursday earnings report
- AMD forecast eases AI spending fears as data-center sales surge
- Broadcom shares climb as AI chip financing deal supports rally
- After-Hours Movers: AMD, SMCI, SWKS, NRIX, TOST, BKNG
- After-Hours Movers: AMZN, TWLO, INTC, SNDK, RDDT, RBLX, PINS, RIVN, SBUX, ILMN
- After-Hours Movers: GOOGL, MSFT, NOW, KLAC. CMG, CVNA, TDOC
- After-Hours Movers: STX, ENPH, HOOD, V, CSGP, BOOM, CAKE, PPG, OI, TER
- After-Hours Movers: CLS, AVGO, CDNS, AMKR, WHR
Medidata Solutions (MDSO) PT Raised to $47 at Jefferies
February 10, 2017 8:07 AM ESTJefferies raised its price target on Medidata Solutions (NASDAQ: MDSO) to $47.00 (from $46.00) while maintaining a Underperform rating.
Analyst David Windley commented, "Based on several triangulations, FY17 revenue guidance appears to mark a very accurate target at the midpoint (not too high or low).... More
SunTrust Upgrades Medidata Solutions (MDSO) to Buy
February 10, 2017 6:47 AM ESTSunTrust Robinson Humphrey upgraded Medidata Solutions (NASDAQ: MDSO) from Hold to Buy with a price target of $70.00.
For an analyst ratings summary and ratings history on Medidata Solutions click here. For more ratings news on Medidata Solutions click here.
Shares of Medidata Solutions closed at $55.80 yesterday.
... MoreMedidata Solutions (MDSO) PT Raised to $65 at Needham & Company on Positive 2017 Guidance
February 10, 2017 6:06 AM ESTNeedham & Company analyst Scott Berg reiterates Buy rating and raises price target on Medidata Solutions (NASDAQ: MDSO) to $65 (from $60), as the company reported strong 2016 fourth quarter results and provided 2017 guidance above estimates.
Berg comments, "Medidata reported strong 4Q16 financial results and initial FY17... More



